These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16173073)

  • 1. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats.
    Liebscher T; Schnell L; Schnell D; Scholl J; Schneider R; Gullo M; Fouad K; Mir A; Rausch M; Kindler D; Hamers FP; Schwab ME
    Ann Neurol; 2005 Nov; 58(5):706-19. PubMed ID: 16173073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
    J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey.
    Freund P; Wannier T; Schmidlin E; Bloch J; Mir A; Schwab ME; Rouiller EM
    J Comp Neurol; 2007 Jun; 502(4):644-59. PubMed ID: 17394135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.
    Weinmann O; Schnell L; Ghosh A; Montani L; Wiessner C; Wannier T; Rouiller E; Mir A; Schwab ME
    Mol Cell Neurosci; 2006; 32(1-2):161-73. PubMed ID: 16697217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats.
    Chen K; Marsh BC; Cowan M; Al'Joboori YD; Gigout S; Smith CC; Messenger N; Gamper N; Schwab ME; Ichiyama RM
    Exp Neurol; 2017 Jun; 292():135-144. PubMed ID: 28341461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.
    Merkler D; Metz GA; Raineteau O; Dietz V; Schwab ME; Fouad K
    J Neurosci; 2001 May; 21(10):3665-73. PubMed ID: 11331396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy.
    Lindau NT; Bänninger BJ; Gullo M; Good NA; Bachmann LC; Starkey ML; Schwab ME
    Brain; 2014 Mar; 137(Pt 3):739-56. PubMed ID: 24355710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-A antibodies and training reduce muscle spasms in spinal cord-injured rats.
    Gonzenbach RR; Gasser P; Zörner B; Hochreutener E; Dietz V; Schwab ME
    Ann Neurol; 2010 Jul; 68(1):48-57. PubMed ID: 20582944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.
    Brösamle C; Huber AB; Fiedler M; Skerra A; Schwab ME
    J Neurosci; 2000 Nov; 20(21):8061-8. PubMed ID: 11050127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion of lesion territory by regenerating fibers after spinal cord injury in adult macaque monkeys.
    Beaud ML; Rouiller EM; Bloch J; Mir A; Schwab ME; Wannier T; Schmidlin E
    Neuroscience; 2012 Dec; 227():271-82. PubMed ID: 23036616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors.
    Fouad K; Dietz V; Schwab ME
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):204-12. PubMed ID: 11690617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats.
    Müllner A; Gonzenbach RR; Weinmann O; Schnell L; Liebscher T; Schwab ME
    Eur J Neurosci; 2008 Jan; 27(2):326-33. PubMed ID: 18215231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.
    Tsai SY; Markus TM; Andrews EM; Cheatwood JL; Emerick AJ; Mir AK; Schwab ME; Kartje GL
    Exp Brain Res; 2007 Sep; 182(2):261-6. PubMed ID: 17717658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1.
    Fouad K; Klusman I; Schwab ME
    Eur J Neurosci; 2004 Nov; 20(9):2479-82. PubMed ID: 15525289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.
    Lenzlinger PM; Shimizu S; Marklund N; Thompson HJ; Schwab ME; Saatman KE; Hoover RC; Bareyre FM; Motta M; Luginbuhl A; Pape R; Clouse AK; Morganti-Kossmann C; McIntosh TK
    Neuroscience; 2005; 134(3):1047-56. PubMed ID: 15979242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
    Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
    Wang X; Zhou T; Maynard GD; Terse PS; Cafferty WB; Kocsis JD; Strittmatter SM
    Brain; 2020 Jun; 143(6):1697-1713. PubMed ID: 32375169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.